Literature DB >> 18930872

Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.

Subish P1, Mishra P, Shankar Pr.   

Abstract

Present study analyzed the pattern, causality, severity and preventability of the systemic adverse drug reactions reported to the regional pharmacovigilance center during the period 14th September 2004 till 13th September 2005. Altogether the centre received 22 systemic adverse drug reactions [males 12 (54.55%), females 10 (45.45%)]. Among the total adverse drug reaction 5 (22.73%) were reported by the Department of Orthopedics. Of the 22 drugs responsible for the suspected adverse drug reaction, majority belongs to the class of opioid analgesics [n=7, (31.82%)], followed by non steroidal anti-inflammatory drugs [n=5, (22.73%)]. Tramadol was the individual drug responsible for 6 (27.27%) adverse drug reactions and vomiting was the most common adverse drug reactions [n=6, (27.27%)]. The causality assessment revealed 7 (31.82%) of the adverse drug reaction to have a probable relationship with the suspected drugs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930872

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  4 in total

1.  Do community pharmacists in Nepal have a role in adverse drug reaction reporting systems?

Authors:  Bhuvan K C; Alian A Alrasheedy; Mohamed Izham Mohamed Ibrahim
Journal:  Australas Med J       Date:  2013-02-28

Review 2.  Methods for assessing the preventability of adverse drug events: a systematic review.

Authors:  Katja Marja Hakkarainen; Karolina Andersson Sundell; Max Petzold; Staffan Hägg
Journal:  Drug Saf       Date:  2012-02-01       Impact factor: 5.606

3.  Pattern of adverse drug reactions reported by the community pharmacists in Nepal.

Authors:  Subish Palaian; Mohamed I M Ibrahim; Pranaya Mishra
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

4.  Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal.

Authors:  Sunil Shrestha; Krisha Danekhu; Bhuvan Kc; Subish Palaian; Mohamed Izham Mohamed Ibrahim
Journal:  Ther Adv Drug Saf       Date:  2020-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.